Microfluidics devices are tiny chips that perform chemical analyses of extremely small volumes of fluids such as blood. Lab-on-a-chip devices, which often use microfluidics, are providing for earlier, more cost-effective disease detection and many other uses, from monitoring to treatment. The global microfluidics market is driven by the demand for low-volume sample analysis and high-throughput screening methodologies and has been fueled by the introduction of advanced technologies, such as lab-on-chip and the demand for in vitro diagnostics (IVDs).

Market Analysis and Insights: Global Medical Microfluidic Devices Market
The global Medical Microfluidic Devices market is valued at US$ XX million in 2019. The market size will reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.

Global Medical Microfluidic Devices Scope and Market Size
Medical Microfluidic Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Medical Microfluidic Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Polymer
Glass
Silicon
Other

Segment by Application
In-vitro Diagnostics (IVD)
Pharmaceuticals and Medical Devices
Other

By Company
Roche
Abbott
Fluidigm Corporation
Johnson & Johnson
Siemens Healthcare
Agilent
Bio-Rad Laboratories

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia